Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Guided Therapeutics (GTHP) Inventory Average (2016 - 2025)

Guided Therapeutics (GTHP) has disclosed Inventory Average for 14 consecutive years, with $515500.0 as the latest value for Q4 2025.

  • Quarterly Inventory Average fell 18.75% to $515500.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $515500.0 through Dec 2025, down 18.75% year-over-year, with the annual reading at $540500.0 for FY2025, 14.55% down from the prior year.
  • Inventory Average hit $515500.0 in Q4 2025 for Guided Therapeutics, down from $589000.0 in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $640000.0 in Q4 2023 to a low of $515500.0 in Q4 2025.
  • Historically, Inventory Average has averaged $599475.0 across 5 years, with a median of $608000.0 in 2021.
  • Biggest five-year swings in Inventory Average: skyrocketed 1074.04% in 2021 and later decreased 18.75% in 2025.
  • Year by year, Inventory Average stood at $580500.0 in 2021, then fell by 1.46% to $572000.0 in 2022, then increased by 11.89% to $640000.0 in 2023, then dropped by 0.86% to $634500.0 in 2024, then fell by 18.75% to $515500.0 in 2025.
  • Business Quant data shows Inventory Average for GTHP at $515500.0 in Q4 2025, $589000.0 in Q3 2025, and $614000.0 in Q2 2025.